EL7.AI
StocksMediumUpdated•Originally published 22 September 2026•Updated 22 September 2026•
2 min read

Rocket Lab Raises $1.944B and Terminates $3.6B Bridge Financing

Key Facts

1Rocket Lab raised approximately $1.944 billion in gross proceeds through the issuance of about 29.3 million shares.
2The company terminated a $3.6 billion bridge commitment, while $1.775 billion of Iridium loans will remain outstanding.
3Rocket Lab expects the acquisition to close in mid-2027 after Iridium shareholder approval and required regulatory clearances.

Rocket Lab completed its at-the-market share-sale program, raising approximately $1.944 billion in gross proceeds through the issuance of about 29.3 million shares before commissions and offering expenses. The company intends to use the net proceeds for cash payments under its pending acquisition of Iridium.

On September 15, 2026, Rocket Lab terminated a $3.6 billion secured bridge financing commitment. Its regulatory filing said the commitment was reduced through a combination of net equity proceeds and $1.775 billion of existing Iridium loans; the company said those sources, together with available cash and other funding, are sufficient for the expected cash payments at closing.

Issuing 29.3 million shares increases the share count, reducing existing investors' ownership percentages and each share's claim on future earnings, all else equal. Terminating the bridge financing removes the need to draw that temporary facility, but it does not eliminate debt: the $1.775 billion of Iridium loans will remain outstanding and receive an unsecured guarantee from Rocket Lab USA when the transaction closes.

The acquisition remains pending, and Rocket Lab expects it to close in mid-2027, subject to Iridium shareholder approval and required regulatory clearances. The decisive next steps are therefore the approvals and closing, rather than raising new bridge financing under the currently disclosed structure.